دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation
Filippo Crea
doi : 10.1093/eurheartj/ehad614
European Heart Journal, Volume 44, Issue 36, 21 September 2023, Pages 3391–3394
Women interventional cardiologists: a glimpse into their extraordinary journeys
Mirvat Alasnag
The CODE-EHR global framework: lifting the veil on health record data
Folkert W. Asselbergs 1,2 and Dipak Kotecha
I am therefore I think
Nandan S. Anavekar1, Kavitha M. Chinnaiyan2, and Ankur Kalra
The promise of a new orally active body weight reducer
Massimo Volpe 1,2* and Daniela Pedicino
Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management: A statement of the ESC Association of Cardiovascular Nursing and Allied Professions (ACNAP), the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association of Preventive Cardiology (EAPC), Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), European Association of Cardiovascular Imaging (EACVI), ESC Regulatory Affairs Committee, ESC Advocacy Committee, ESC Digital Health Committee, ESC Education Committee, and the ESC Patient Forum
Philip Moons 1,2,3*, Tone M. Norekv?l 4,5, Elena Arbelo 6,7,8, Britt Borregaard 9,10, Barbara Casadei 11,12, Bernard Cosyns 13, Martin R. Cowie 14, Donna Fitzsimons 15, Alan G. Fraser 16, Tiny Jaarsma 17,18, Paulus Kirchhof 19,20,21, Josepa Mauri 22, Richard Mindham 23, Julie Sanders 24,25, Francois Schiele 26, Aleksandra Torbica 27, and Ann Dorthe Zwisler
Vegetarian and vegan diets: benefits and drawbacks
Tian Wang 1,2, Andrius Masedunskas 1,2, Walter C. Willett3, and Luigi Fontana
Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
Wilton A. van Klei 1,2,3*, Judith A. R. van Waes3, and W. Scott Beattie
New-onset atrial fibrillation prediction: the HARMS2-AF risk score
Louise Segan 1,2,3 , Rodrigo Canovas 2,4,5 , Shane Nanayakkara 1,2,6 , David Chieng1,2,3 , Sandeep Prabhu 1,2,3 , Aleksandr Voskoboinik 1,2,3 , Hariharan Sugumar 1,2,3 , Liang-Han Ling 1,2,3 , Geoff Lee3,7 , Joseph Morton 3,7 , Andre LaGerche 1,2,3 , David M. Kaye 1,2,6 , Prashanthan Sanders 8,9 , Jonathan M. Kalman3,7 , and Peter M. Kistler
Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities
Gregory M. Marcus
Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study
So Mi Jemma Cho 1,2,3 , Satoshi Koyama 1,2 , Michael C. Honigberg 1,2,4,5 , Ida Surakka 1,6 , Sara Haidermota 1,2 , Shriienidhie Ganesh1,2 , Aniruddh P. Patel 1,2,4,5 , Romit Bhattacharya 1,2,4,5 , Hokyou Lee 7 , Hyeon Chang Kim 3,7,8 , and Pradeep Natarajan
Can we measurably improve the prediction of recurrent coronary artery disease events?
William S. Weintraub 1* and William E. Boden
Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study
Christian Valdemar Skibsted 1,2 *, Kasper Korsholm 2,3 , Lars Pedersen 1,2 , Kasper Bonnesen 1,2 , Jens Erik Nielsen-Kudsk 2,3 , and Morten Schmidt
Should the risk of atrial fibrillation deter PFO closure for cryptogenic ischaemic stroke?
A. John Camm
Remnant cholesterol as a lipid-lowering target may have a long way to go
Ye-Xuan Cao 1,2 , Ke-Fei Dou1 , and Jian-Jun Li
Remnant cholesterol in the era of intensive lipid-lowering therapies
Benjamin N. Wadstr?m 1,2,3 , Anders B. Wulff 1,2,3 , Kasper M. Pedersen 1,2,3 , and B?rge G. Nordestgaard
Refractory pulmonary artery intimal sarcoma
Shogo Ito*, Nobuhiro Tahara *, and Yoshihiro Fukumoto
Stunning tornado: severe pulmonary hypertension due to cor triatriatum sinister
Xuan Zheng , Jinsong Cao, and Gangcheng Zhang
